153 related articles for article (PubMed ID: 33442232)
1. Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?
Yu Q; Sun Y
Drug Des Devel Ther; 2021; 15():1-8. PubMed ID: 33442232
[TBL] [Abstract][Full Text] [Related]
2. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
Zhao Y; Morgan MA; Sun Y
Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compounds.
Wu K; DeVita RJ; Pan ZQ
J Biol Chem; 2024 Mar; 300(3):105752. PubMed ID: 38354780
[TBL] [Abstract][Full Text] [Related]
4. Protein neddylation and its role in health and diseases.
Zhang S; Yu Q; Li Z; Zhao Y; Sun Y
Signal Transduct Target Ther; 2024 Apr; 9(1):85. PubMed ID: 38575611
[TBL] [Abstract][Full Text] [Related]
5. A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation.
Zhou H; Lu J; Liu L; Bernard D; Yang CY; Fernandez-Salas E; Chinnaswamy K; Layton S; Stuckey J; Yu Q; Zhou W; Pan Z; Sun Y; Wang S
Nat Commun; 2017 Oct; 8(1):1150. PubMed ID: 29074978
[TBL] [Abstract][Full Text] [Related]
6. Proapoptotic effect of WS-299 induced by NOXA accumulation and NRF2-counterbalanced oxidative stress damage through targeting RBX1-UBE2M interaction in gastric cancers.
Ma T; Song Q; Cheng B; Guo E; Wang X; Li M; Dai M; Li S; Feng S; Yu B
Bioorg Chem; 2024 Mar; 144():107142. PubMed ID: 38280358
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.
Wei D; Morgan MA; Sun Y
Transl Oncol; 2012 Oct; 5(5):305-12. PubMed ID: 23066438
[TBL] [Abstract][Full Text] [Related]
8. Targeting the mTOR-DEPTOR pathway by CRL E3 ubiquitin ligases: therapeutic application.
Zhao Y; Sun Y
Neoplasia; 2012 May; 14(5):360-7. PubMed ID: 22745582
[TBL] [Abstract][Full Text] [Related]
9. Cullin-5 neddylation-mediated NOXA degradation is enhanced by PRDX1 oligomers in colorectal cancer.
Xu S; Ma Y; Tong Q; Yang J; Liu J; Wang Y; Li G; Zeng J; Fang S; Li F; Xie X; Zhang J
Cell Death Dis; 2021 Mar; 12(3):265. PubMed ID: 33712558
[TBL] [Abstract][Full Text] [Related]
10. NNMT/1-MNA Promote Cell-Cycle Progression of Breast Cancer by Targeting UBC12/Cullin-1-Mediated Degradation of P27 Proteins.
Ma Y; Huang X; Wang Y; Lei Y; Yu J; Yu S; Gao Y; Yang J; Zhao F; Yu H; Zeng J; Chu Y; Yang M; Li G; Xie X; Zhang J
Adv Sci (Weinh); 2024 Mar; 11(9):e2305907. PubMed ID: 38126621
[TBL] [Abstract][Full Text] [Related]
11. Emerging Roles of Cullin-RING Ubiquitin Ligases in Cardiac Development.
Zambrano-Carrasco J; Zou J; Wang W; Sun X; Li J; Su H
Cells; 2024 Jan; 13(3):. PubMed ID: 38334627
[TBL] [Abstract][Full Text] [Related]
12. The Role of Cullin-RING Ligases in Striated Muscle Development, Function, and Disease.
Blondelle J; Biju A; Lange S
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114658
[TBL] [Abstract][Full Text] [Related]
13. Noncanonical assembly, neddylation and chimeric cullin-RING/RBR ubiquitylation by the 1.8 MDa CUL9 E3 ligase complex.
Horn-Ghetko D; Hopf LVM; Tripathi-Giesgen I; Du J; Kostrhon S; Vu DT; Beier V; Steigenberger B; Prabu JR; Stier L; Bruss EM; Mann M; Xiong Y; Schulman BA
Nat Struct Mol Biol; 2024 Apr; ():. PubMed ID: 38605244
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Potent and Selective 2-(Benzylthio)pyrimidine-based DCN1-UBC12 Inhibitors for Anticardiac Fibrotic Effects.
He ZX; An Q; Wei B; Zhou WJ; Wei BF; Gong YP; Zhang X; Gao G; Dong GJ; Huo JL; Zhang XH; Yang FF; Liu HM; Ma LY; Zhao W
J Med Chem; 2022 Jan; 65(1):163-190. PubMed ID: 34939411
[TBL] [Abstract][Full Text] [Related]
15. Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells.
Chen YF; Liu RZ; Ying WW; Yang YN; Xiang SF; Shao XJ; Cao J; Zhang YQ; Yang B; He QJ; Ying MD
Acta Pharmacol Sin; 2023 Mar; 44(3):661-669. PubMed ID: 36138144
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase.
Brewitz L; Tumber A; Zhang X; Schofield CJ
Bioorg Med Chem; 2020 Oct; 28(20):115675. PubMed ID: 33069066
[TBL] [Abstract][Full Text] [Related]
17. Discovery and characterization of potent And-1 inhibitors for cancer treatment.
Li J; Zhang Y; Sun J; Chen L; Gou W; Chen CW; Zhou Y; Li Z; Chan DW; Huang R; Pei H; Zheng W; Li Y; Xia M; Zhu W
Clin Transl Med; 2021 Dec; 11(12):e627. PubMed ID: 34923765
[TBL] [Abstract][Full Text] [Related]
18. Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches.
Miao Q; Kadam VD; Mukherjee A; Tan Z; Teng M
J Med Chem; 2023 Oct; 66(19):13369-13383. PubMed ID: 37738232
[TBL] [Abstract][Full Text] [Related]
19. Correction to: Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2‑Antisense RNA 1/microRNA‑93‑5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis.
Wu X; Xu Q; Li T; Wei Y; Zeng R; Lin R; Xu L; Ye L; Liu Z
Appl Biochem Biotechnol; 2023 Dec; 195(12):7898-7899. PubMed ID: 37052864
[No Abstract] [Full Text] [Related]
20. Neddylation regulation of mitochondrial structure and functions.
Zhou Q; Zheng Y; Sun Y
Cell Biosci; 2021 Mar; 11(1):55. PubMed ID: 33731189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
